242 related articles for article (PubMed ID: 31603760)
1. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
[TBL] [Abstract][Full Text] [Related]
2. SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence.
Punia K; Scott W; Manuja K; Sabbineni M; Campbell K; Balodis IM; MacKillop J
Acad Emerg Med; 2024 May; 31(5):504-514. PubMed ID: 37735346
[TBL] [Abstract][Full Text] [Related]
3. Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls.
Fairbanks J; Umbreit A; Kolla BP; Karpyak VM; Schneekloth TD; Loukianova LL; Sinha S
Mayo Clin Proc; 2020 Sep; 95(9):1964-1977. PubMed ID: 32446635
[TBL] [Abstract][Full Text] [Related]
4. Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features.
Grant JE; Potenza MN; Kraus SW; Petrakis IL
J Clin Psychiatry; 2017; 78(9):e1299-e1306. PubMed ID: 29345864
[TBL] [Abstract][Full Text] [Related]
5. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
Williams EC; Matson TE; Harris AHS
Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
[TBL] [Abstract][Full Text] [Related]
6. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
[TBL] [Abstract][Full Text] [Related]
7. Veteran adherence to oral versus injectable AUD medication treatment.
Stewart H; Mitchell BG; Ayanga D; Walder A
Ment Health Clin; 2021 May; 11(3):194-199. PubMed ID: 34026395
[TBL] [Abstract][Full Text] [Related]
8. Rates of prescription orders for United States active duty service members diagnosed with alcohol use disorder.
Peters ZJ; Kincaid MW; Greenberg JG; Quah RF; Curry JC
Subst Abus; 2021; 42(4):638-645. PubMed ID: 32870103
[No Abstract] [Full Text] [Related]
9. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
[TBL] [Abstract][Full Text] [Related]
10. [Use of drugs for alcohol use disorder in Norway 2004–16].
Heldal AT; Skurtveit S; Lobmaier PPK; Vederhus JK; Bramness JG
Tidsskr Nor Laegeforen; 2018 Nov; 138(18):. PubMed ID: 30421743
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
Kranzler HR; Soyka M
JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
[TBL] [Abstract][Full Text] [Related]
12. Medication treatment for alcohol use disorder in special populations.
Malhotra A; Drexler K; Hsu M; Tang YL
Am J Addict; 2023 Sep; 32(5):433-441. PubMed ID: 37551638
[TBL] [Abstract][Full Text] [Related]
13. Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder.
Muvvala SB; O'Malley SS; Rosenheck R
Am J Addict; 2021 Jan; 30(1):55-64. PubMed ID: 32805083
[TBL] [Abstract][Full Text] [Related]
14. Adherence to extended release naltrexone: Patient and treatment characteristics.
Chang G; Crawford M; Pitts M; Schein AZ; Goodwin K; Enggasser JL
Am J Addict; 2018 Sep; 27(6):524-530. PubMed ID: 30106489
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for alcohol misuse in correctional settings: A systematic review.
Slavin-Stewart C; Minhas M; Turna J; Brasch J; Olagunju AT; Chaimowitz G; MacKillop J
Alcohol Clin Exp Res; 2022 Jan; 46(1):13-24. PubMed ID: 34825363
[TBL] [Abstract][Full Text] [Related]
16. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans.
Arias AJ; Gelernter J; Gueorguieva R; Ralevski E; Petrakis IL
Am J Addict; 2014; 23(3):288-93. PubMed ID: 24724887
[TBL] [Abstract][Full Text] [Related]
18. Prescription Drug and Alcohol Use Disorders: Alcohol Use Disorder.
Warren D
FP Essent; 2019 Mar; 478():30-42. PubMed ID: 30844223
[TBL] [Abstract][Full Text] [Related]
19. Very Low Frequency of Drug Therapy of Alcohol Dependence in Germany - Analysis of Data of A Statutory Health Insurance.
Scherbaum N; Holzbach R; Stammen G; Kirchof U; Bonnet U
Pharmacopsychiatry; 2020 Jan; 53(1):37-39. PubMed ID: 31132796
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?
Antonelli M; Sestito L; Tarli C; Addolorato G
Eur J Intern Med; 2022 Sep; 103():13-22. PubMed ID: 35597734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
